Professor Simon Harrison is the Director, Centre of Excellence for Cellular Immunotherapy at VCCC and the Peter MacCallum Cancer Centre, Director of Clinical Apheresis, and a Clinician Scientist in the Sir Peter MacCallum department of Oncology in Melbourne University. He is a leading Australia Myeloma clinician and chair of the Myeloma Scientific Advisory Group at Myeloma Australia.

In clinical research, Professor Harrison’s clinical research is focused in the field of multiple myeloma examining novel therapies including novel drug combinations, early phase clinical trial design and the development of cellular and bi-specific antibody immunotherapy therapy.

In laboratory research, Professor Harrison’s work focuses on the development of novel cellular immune therapies in cancer and in vivo cell tracking. He is also a lead in the development of small molecule development such as POL1 inhibitors and venetoclax in combination with other novel drugs.